220 related articles for article (PubMed ID: 28202042)
1. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.
Shah M; Cardenas R; Wang B; Persson J; Mongan NP; Grabowska A; Allegrucci C
Mol Cancer; 2017 Feb; 16(1):38. PubMed ID: 28202042
[TBL] [Abstract][Full Text] [Related]
2. DNA Methylation-Regulated HOXC8's Role in HER2-Positive Breast Cancer Function and its Contribution to Herceptin Resistance.
Xie X; Tang S; Yu Z
Discov Med; 2024 Mar; 36(182):559-570. PubMed ID: 38531796
[TBL] [Abstract][Full Text] [Related]
3. Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells.
Prajapati KS; Kumar S
J Cell Biochem; 2023 Aug; 124(8):1186-1202. PubMed ID: 37436061
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene.
Phua YW; Nguyen A; Roden DL; Elsworth B; Deng N; Nikolic I; Yang J; Mcfarland A; Russell R; Kaplan W; Cowley MJ; Nair R; Zotenko E; O'Toole S; Tan SX; James DE; Clark SJ; Kouros-Mehr H; Swarbrick A
Breast Cancer Res; 2015 Jun; 17(1):83. PubMed ID: 26070602
[TBL] [Abstract][Full Text] [Related]
5. Hoxc8 downregulates Mgl1 tumor suppressor gene expression and reduces its concomitant function on cell adhesion.
Ruthala K; Gadi J; Lee JY; Yoon H; Chung HJ; Kim MH
Mol Cells; 2011 Sep; 32(3):273-9. PubMed ID: 21773674
[TBL] [Abstract][Full Text] [Related]
6. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
[No Abstract] [Full Text] [Related]
7. Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture.
Dey D; Saxena M; Paranjape AN; Krishnan V; Giraddi R; Kumar MV; Mukherjee G; Rangarajan A
PLoS One; 2009; 4(4):e5329. PubMed ID: 19390630
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor.
Hong D; Fritz AJ; Finstad KH; Fitzgerald MP; Weinheimer A; Viens AL; Ramsey J; Stein JL; Lian JB; Stein GS
Mol Cancer Res; 2018 Dec; 16(12):1952-1964. PubMed ID: 30082484
[TBL] [Abstract][Full Text] [Related]
9. MEIS2 suppresses breast cancer development by downregulating IL10.
Xiao Y; Liu Y; Sun Y; Huang C; Zhong S
Cancer Rep (Hoboken); 2024 May; 7(5):e2064. PubMed ID: 38711262
[TBL] [Abstract][Full Text] [Related]
10.
Wu HT; Wu Z; Hou YY; Fang ZX; Wu BX; Deng Y; Cui YK; Liu J
Epigenomics; 2023 Sep; 15(18):911-925. PubMed ID: 37905439
[No Abstract] [Full Text] [Related]
11. Genes Frequently Coexpressed with Hoxc8 Provide Insight into the Discovery of Target Genes.
Kalyani R; Lee JY; Min H; Yoon H; Kim MH
Mol Cells; 2016 May; 39(5):395-402. PubMed ID: 27025388
[TBL] [Abstract][Full Text] [Related]
12. s-SHIP Promoter Expression Identifies Mouse Mammary Cancer Stem Cells.
Tian L; Truong MJ; Lagadec C; Adriaenssens E; Bouchaert E; Bauderlique-Le Roy H; Figeac M; Le Bourhis X; Bourette RP
Stem Cell Reports; 2019 Jul; 13(1):10-20. PubMed ID: 31204299
[TBL] [Abstract][Full Text] [Related]
13. Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties.
Mavingire N; Campbell P; Liu T; Wooten J; Khan S; Chen X; Matthews J; Wang C; Brantley E
Precis Clin Med; 2022 Jun; 5(2):pbac008. PubMed ID: 35694715
[TBL] [Abstract][Full Text] [Related]
14. Effects of HOXC8 on the Proliferation and Differentiation of Porcine Preadipocytes.
Cui W; Zhang Q; Wang H; Zhang X; Tian M; Liu D; Yang X
Animals (Basel); 2023 Aug; 13(16):. PubMed ID: 37627406
[TBL] [Abstract][Full Text] [Related]
15. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
Guo L; Li F; Liu H; Kong D; Chen C; Sun S
J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
[TBL] [Abstract][Full Text] [Related]
16.
Tsai CY; Liao JB; Lee YC; Yang YF
J Cancer; 2023; 14(13):2552-2561. PubMed ID: 37670969
[TBL] [Abstract][Full Text] [Related]
17. Absence of an embryonic stem cell DNA methylation signature in human cancer.
Zhang Z; Wiencke JK; Koestler DC; Salas LA; Christensen BC; Kelsey KT
BMC Cancer; 2019 Jul; 19(1):711. PubMed ID: 31324166
[TBL] [Abstract][Full Text] [Related]
18. The identification of Hoxc8 target genes.
Lei H; Wang H; Juan AH; Ruddle FH
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2420-4. PubMed ID: 15699330
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development.
Deng L; Shang L; Bai S; Chen J; He X; Martin-Trevino R; Chen S; Li XY; Meng X; Yu B; Wang X; Liu Y; McDermott SP; Ariazi AE; Ginestier C; Ibarra I; Ke J; Luther T; Clouthier SG; Xu L; Shan G; Song E; Yao H; Hannon GJ; Weiss SJ; Wicha MS; Liu S
Cancer Res; 2014 Nov; 74(22):6648-60. PubMed ID: 25217527
[TBL] [Abstract][Full Text] [Related]
20. ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells.
Luo M; Bao L; Chen Y; Xue Y; Wang Y; Zhang B; Wang C; Corley CD; McDonald JG; Kumar A; Xing C; Fang Y; Nelson ER; Wang JE; Wang Y; Luo W
Sci Adv; 2022 Jul; 8(28):eabn5295. PubMed ID: 35857506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
